A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
NCT01466855
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
36
Enrollment
OTHER
Sponsor class
Stopped
Competing studies
Conditions
Retinoblastoma
Interventions
DRUG:
Intra-Ophthalmic Artery Topotecan Infusion
Sponsor
Children's Hospital Medical Center, Cincinnati